Nordamnacanthal potentiates the cytotoxic effects of tamoxifen in human breast cancer cells

Tamoxifen (TAM) is the mainline drug treatment for breast cancer, despite its side effects and the development of resistance. As an alternative approach, in the present study a novel combination therapy was established through combining TAM with nordamnacanthal (NDAM) in order to investigate the add...

Descripción completa

Detalles Bibliográficos
Autores principales: SUBRAMANI, TAMILSELVAN, YEAP, SWEE KEONG, HO, WAN YANG, HO, CHAI LING, OSMAN, CHE PUTEH, ISMAIL, NOR HADIANI, RAHMAN, NIK MOHD AFIZAN NIK ABDUL, ALITHEEN, NOORJAHAN BANU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247001/
https://www.ncbi.nlm.nih.gov/pubmed/25435988
http://dx.doi.org/10.3892/ol.2014.2697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247001/
https://www.ncbi.nlm.nih.gov/pubmed/25435988
http://dx.doi.org/10.3892/ol.2014.2697

Ejemplares similares